Intervention Review

Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis

  1. Troels Wienecke1,*,
  2. Peter C Gøtzsche2

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 26 JAN 2004

Assessed as up-to-date: 31 JUL 2007

DOI: 10.1002/14651858.CD003789.pub2

How to Cite

Wienecke T, Gøtzsche PC. Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003789. DOI: 10.1002/14651858.CD003789.pub2.

Author Information

  1. 1

    Køge, Denmark

  2. 2

    Rigshospitalet, Dept. 3343, The Nordic Cochrane Centre, Copenhagen Ø, Denmark

*Troels Wienecke, Ørbækvænge 7, Køge, 4600, Denmark.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004


Cited in:


This article has been cited by:

  1. 1
    R.A. Moore, S. Derry, P.J. Wiffen, S. Straube, D.J. Aldington, Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions, European Journal of Pain, 2015, 19, 9
  2. 2
    Thomas E. Finucane, Olivia Nirmalasari, Antonio Graham, Palliative Care in the Ambulatory Geriatric Practice, Clinics in Geriatric Medicine, 2015, 31, 2, 193


  3. 3
    Ula Hwang, Timothy F. Platts-Mills, Acute Pain Management in Older Adults in the Emergency Department, Clinics in Geriatric Medicine, 2013, 29, 1, 151


  4. You have free access to this content4
    Bruno Georg Oertel, Jörn Lötsch, Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research, British Journal of Pharmacology, 2013, 168, 3
  5. 5
    Corrine I. Voils, YunKyung Chang, Jamie Crandell, Jennifer Leeman, Margarete Sandelowski, Matthew L. Maciejewski, Informing the dosing of interventions in randomized trials, Contemporary Clinical Trials, 2012, 33, 6, 1225


  6. 6
    B.C. Garrido López, F. Navarro Sarabia, E.M. Montero Martín, Antiinflamatorios no esteroideos: farmacodinámica, reacciones adversas e indicaciones en reumatología, Medicine - Programa de Formación Médica Continuada Acreditado, 2011, 10, 92, 6255


  7. 7
    David L Scott, Frederick Wolfe, Tom WJ Huizinga, Rheumatoid arthritis, The Lancet, 2010, 376, 9746, 1094


  8. 8
    Peter Tugwell, Lara Maxwell, Vivian Welch, Elizabeth Kristjansson, Mark Petticrew, George Wells, Rachelle Buchbinder, Maria E. Suarez-Almazor, Marie-Andrée Nowlan, Erin Ueffing, Maryam Khan, Bev Shea, Setorme Tsikata, Is health equity considered in systematic reviews of the cochrane musculoskeletal group?, Arthritis Care & Research, 2008, 59, 11
  9. 9
    Bernard Combe, Early rheumatoid arthritis: strategies for prevention and management, Best Practice & Research Clinical Rheumatology, 2007, 21, 1, 27


  10. 10
    John H. Noble, Meta-analysis: Methods, strengths, weaknesses, and political uses, Journal of Laboratory and Clinical Medicine, 2006, 147, 1, 7


  11. 11
    Jean-Noel Vergnes, Paul Monsarrat, Alessandra Blaizot, Cathy Nabet, Alain Cantagrel, Michel Sixou, Susan Furness, Interventions for periodontal disease in people with rheumatoid arthritis, The Cochrane Library,
  12. 12
    Paul Creamer, Sarah Love-Jones, Pain Associated with Rheumatoid Arthritis,
  13. 13
    Troels Wienecke, Peter C Gøtzsche, Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis, The Cochrane Library,